Skip to content

Pharmaceutical Pre-Approval Inspections, 2/E, Vol.181 (Ex): A Guide To
Stock Photo: Cover May Be Different

Pharmaceutical Pre-Approval Inspections, 2/E, Vol.181 (Ex): A Guide To Regulatory Success Hardcover - 2008

by Brittain H.G.,Deb,Deb A.K,Ebadi M.,Graebel,Graebel W. P,Hynes M.D.,Kalacska,Kalacska M.,Lelieveld H.L.M,Lewis,Rossell J.B,Salunkhe D.K.,Seethala R.,Signore A.A.,Silverman,Silverman R. B,Thassu D.,Vasic,Vasic B.,Whitaker,Zeng,Zeng X.M

  • New

Description

Taylor & Francis, 2008. New.
New
NZ$187.11
NZ$24.96 Shipping to USA
Standard delivery: 20 to 30 days
More Shipping Options
Ships from BookVistas (Delhi, India)

Details

About BookVistas Delhi, India

Biblio member since 2011
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

Terms of Sale:

30 day return guarantee, with full refund including shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

All books are new.

Additional shipping charges may be required for multi-volume sets.

Browse books from BookVistas

From the publisher

Rev. ed. of: Preparing for FDA pre-approval inspections. c1999. Includes bibliographical references and index.

About the author

MARTIN D. HYNES III is Director of Product Research and Development and Six Sigma Champion at Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana. Dr. Hynes has authored or co-authored numerous scientific articles, abstracts, book chapters, books, and patents. He is a member of a number of scientific and industry organizations. He has spoken and served as session chair at meetings of these organizations on numerous occasions. Dr. Hynes earned his bachelor's degree in psychology from Providence College and his Ph.D. in pharmacology and toxicology from the University of Rhode Island. After completing a post-doctoral fellowship at the Roche Institute of Molecular Biology, he joined Lilly Research Labs. He has held several management positions, including Director of Pharmaceutical Project Management, Director of Quality Assurance, and Director for Clinical Research for Eli Lilly, Japan.